Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | GGPS1 | O95749 | 6/20 | 0.34 |
| ▸ | FDPS | P14324 | 9/20 | 0.33 |
| ▸ | SMPD1 | P17405 | 2/20 | 0.32 |
| ▸ | CES2 | O00748 | 1/20 | 0.32 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.32 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10797646 | 0.80 | TSHR (0.50) | TSHRTHRBGGPS1FDPSSMPD1 | |
| SCHEMBL10416462 | 0.80 | TSHR (0.50) | TSHRTHRBGGPS1FDPSSMPD1 | |
| SCHEMBL8687202 | 0.80 | TSHR (0.50) | TSHRTHRBGGPS1FDPSSMPD1 | |
| SCHEMBL17351709 | 0.80 | TSHR (0.50) | TSHRTHRBGGPS1FDPSSMPD1 | |
| SCHEMBL16209482 | 0.78 | TSHR (0.47) | TSHRTHRBGGPS1FDPSSMPD1 | |
| SCHEMBL16496835 | 0.75 | — | — | |
| SCHEMBL7752834 | 0.75 | TSHR (0.41) | TSHRTHRBGGPS1FDPSSMPD1 | |
| SCHEMBL28214778 | 0.74 | TSHR (0.38) | TSHRTHRBGGPS1FDPSSMPD1 | |
| SCHEMBL5964919 | 0.74 | TSHR (0.38) | TSHRTHRBGGPS1FDPSSMPD1 | |
| SCHEMBL5848545 | 0.74 | TSHR (0.33) | TSHRTHRBGGPS1FDPSSMPD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8501788-B2 | Process for recovering flunixin from pharmaceutical compositions | INTERVET INC. (US) | 2013-08-06 | — | — | US | disclosed |
| EP-2229149-B1 | PROCESS FOR RECOVERING FLUNIXIN FROM PHARMACEUTICAL COMPOSITIONS | INTERVET INT BV (NL) | 2012-03-07 | — | — | EP | disclosed |
| EP-2358357-A1 | PROCESS FOR RECOVERING FLORFENICOL FROM PHARMACEUTICAL COMPOSITIONS | Intervet International B.V. (NL) | 2011-08-24 | — | — | EP | disclosed |
| US-20100331376-A1 | Process for Recovering Flunixin From Pharmaceutical Compositions | INTERVET INC. | 2010-12-30 | — | — | US | disclosed |
| EP-2229149-A1 | PROCESS FOR RECOVERING FLUNIXIN FROM PHARMACEUTICAL COMPOSITIONS | Intervet International B.V. (NL) | 2010-09-22 | — | — | EP | disclosed |
| WO-2010059259-A1 | PROCESS FOR RECOVERING FLORFENICOL FROM PHARMACEUTICAL COMPOSITIONS | SCHERING-PLOUGH LTD. (CH) | 2010-05-27 | — | — | WO | disclosed |
| US-20090170954-A1 | Process for Recovering Florfenicol and Florfenicol Analogs | SCHERING-PLOUGH LTD. (CH) | 2009-07-02 | — | — | US | disclosed |
| WO-2009079345-A1 | PROCESS FOR RECOVERING FLUNIXIN FROM PHARMACEUTICAL COMPOSITIONS | SCHERING-PLOUGH LTD. (CH) | 2009-06-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100331376-A1 | Process for Recovering Flunixin From Pharmaceutical Compositions | RDX, LPXN, FLNB | TSHR 394/4885THRB 1625/4885GGPS1 3586/4885 |
| US-20090170954-A1 | Process for Recovering Florfenicol and Florfenicol Analogs | FDPS, FAU, PFAS | TSHR 2811/4885THRB 3261/4885GGPS1 127/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.